Re: challenge grants Dolce, Peter J 21 Jul 2009 11:07 EST
IRG is the Initial Review Group of scientists who perform the first (hence "initial") review for scientific merit in NIH's 2-step review process. After the IRG finishes, a national research council (there's one of these for each NIH institute) performs the second stage of the review. The message means that the proposal is queued up to go to the first stage of review. This is the forum where all of us can ask dumb questions, and that's one of its most valuable features, so keep asking. PJD Peter J. Dolce, Ph.D. Associate Vice President for Research Meharry Medical College West Basic Sciences Center 1023 21st Avenue North Nashville, TN 37208 Phone 615 327 6237 Fax 615 327 6144 -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Watercutter, Rebecca Sent: Tuesday, July 21, 2009 10:54 AM To: xxxxxx@hrinet.org Subject: Re: [RESADM-L] challenge grants OK. I know this makes me look really dumb, but what does it mean when status reads: Pending IRG review? -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Jon Teuber Sent: Monday, July 20, 2009 10:43 AM To: xxxxxx@hrinet.org Subject: Re: [RESADM-L] challenge grants They are definitely holding these proposals to the limitations posted. One of our PIs received a letter saying his proposal was removed because he had over 10 references. We checked and double checked, and appealed because both the PI and co-PI had exactly 10 each. On appeal, NIH responded that their first finding was incorrect, and that instead the PI had over one page of references (also a limit)... that error finding was valid. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== DISCLAIMER: This email and any files transmitted with it may be privileged, confidential, and contain health information that is legally protected. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless permitted to do so by law or regulation. If you are not the intended recipient, you are hereby notified that any use, disclosure, copying, or distribution, is strictly prohibited. If you have received this information in error, please notify the sender immediately and arrange for the return or destruction of these documents. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================